Role of Akt signaling in resistance to DNA-targeted therapy
about
Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.The prognostic value of PI3K mutational status in breast cancer: a meta-analysis.Alex3 suppresses non-small cell lung cancer invasion via AKT/Slug/E-cadherin pathway.Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.
P2860
Role of Akt signaling in resistance to DNA-targeted therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Role of Akt signaling in resistance to DNA-targeted therapy
@ast
Role of Akt signaling in resistance to DNA-targeted therapy
@en
Role of Akt signaling in resistance to DNA-targeted therapy
@nl
type
label
Role of Akt signaling in resistance to DNA-targeted therapy
@ast
Role of Akt signaling in resistance to DNA-targeted therapy
@en
Role of Akt signaling in resistance to DNA-targeted therapy
@nl
prefLabel
Role of Akt signaling in resistance to DNA-targeted therapy
@ast
Role of Akt signaling in resistance to DNA-targeted therapy
@en
Role of Akt signaling in resistance to DNA-targeted therapy
@nl
P2093
P2860
P3181
P356
P1476
Role of Akt signaling in resistance to DNA-targeted therapy
@en
P2093
Abolfazl Avan
Godefridus J Peters
Ravi Narayan
P2860
P304
P3181
P356
10.5306/WJCO.V7.I5.352
P407
P577
2016-10-10T00:00:00Z